Missing anticitrullinated protein antibody does not affect short-term outcomes in early inflammatory arthritis: From the Canadian early arthritis cohort Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Anti-Idiotypic
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Peptides, Cyclic
  • Rheumatoid Factor

abstract

  • There was no care gap in the RF-negative, unknown ACPA group because there were no significant differences in the DAS28, 3-month change in DAS28, or HAQ-DI, despite less treatment. Cost-effectiveness of ensuring ACPA testing availability in suspected RA is unknown because early outcomes did not differ, whether or not ACPA was available.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.150260

PubMed ID

  • 26329342

Additional Document Info

start page

  • 2023

end page

  • 8

volume

  • 42

number

  • 11